Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | |
| Sales | 3,357,000 | 0 |
| Cost of Goods | 2,742,000 | N/A |
| Gross Profit | 615,000 | N/A |
| Operating Expenses | 555,000 | 0 |
| Operating Income | 60,000 | N/A |
| Other Income | -3,000 | 0 |
| Pre-tax Income | 57,000 | 0 |
| Income Tax | 14,000 | N/A |
| Net Income Continuous | 43,000 | N/A |
| Net Income | $43,000 | $N/A |
| EPS Basic Total Ops | 0.37 | N/A |
| EPS Basic Continuous Ops | 0.37 | N/A |
| EPS Diluted Total Ops | 0.37 | N/A |
| EPS Diluted Continuous Ops | 0.37 | N/A |
| EBITDA(a) | $136,000 | $N/A |